Products

eMurmur Heart AI
CSD Labs
Cardiology AI
eMurmur Heart AI by CSD Labs is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings.
eMurmur ID
CSD Labs GmbH
Cardiology AI
AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers.

See all 2 products →

About CSD Labs

CSD Labs, operating under the brand name eMurmur, is a pioneering healthcare AI company focused on revolutionizing cardiac auscultation. Their flagship product is an AI-powered, telehealth-enabled stethoscope platform designed for the objective detection and classification of heart murmurs. The eMurmur system comprises a mobile application, server-based heart sound analysis medical software, and a comprehensive auscultation database. This clinically validated medical device aids healthcare professionals in performing standardized auscultations by analyzing and classifying heart sounds acquired via electronic stethoscopes.

The platform aims to enhance diagnostic accuracy, reduce the rate of unnecessary referrals to specialists, and streamline clinical workflows. It offers capabilities for electronic documentation of auscultation findings, integration into electronic patient records, and facilitates tele-consultation for expert opinions, thereby improving patient care and reducing healthcare costs. eMurmur’s technology is powered by SADIE (Machine Intelligence Signal Analysis/Diagnosis Engine) and has received FDA clearance, enabling its use across various digital stethoscope models and third-party software.

What Physicians Need to Know

AI-Powered Auscultation
CSD Labs specializes in medical AI, specifically eMurmur's Heart AI, for analyzing heart and lung sounds recorded with digital stethoscopes. This AI automatically identifies primary heart sounds and detects the presence and absence of abnormal heart murmurs.
FDA & CE Cleared
eMurmur's Open Medical AI, including its Heart AI suite, has received multiple FDA clearances and CE markings, establishing CSD Labs as an industry leader in auscultation AI in both the US and EU.
Hardware-Agnostic Platform
A key differentiator is eMurmur's 'open platform' approach, enabling murmur detection across various digital stethoscope models (e.g., Eko Health, 3M Littmann, Thinklabs, HD Medical, Cardionics, Welch Allyn) and third-party software.
Hemodynamic Insights
Beyond basic murmur detection, eMurmur Heart AI provides hemodynamic insights by calculating the energy of specific heart sound components, including S1, S2, systole, and diastole.
Telehealth & Remote Capabilities
The platform supports remote stethoscope exams during virtual visits, pharmacy and community-based screenings, and home-health applications, facilitating tele-auscultation and asynchronous sharing for remote consultation.
Validated Accuracy
Clinical trials have demonstrated high sensitivity (93%) and specificity (81%) for detecting pathologic murmurs, comparable to specialist auscultation, with an overall accuracy of 88%.
Physician Tip

Leverage eMurmur's AI for objective heart murmur detection to augment your clinical judgment, especially in screening and monitoring patients with suspected cardiac conditions. Integrate eMurmur with your existing digital stethoscopes and telehealth platforms to streamline auscultation workflows and enable remote cardiac assessments. Utilize the hemodynamic insights provided by the AI to gain a deeper understanding of heart sound components and inform patient management strategies. Take advantage of the platform's ability to store and compare auscultation data over time for effective patient monitoring and specialist consultations.

eMurmur's 'Open Medical AI' is designed for broad compatibility, integrating seamlessly with a wide range of digital stethoscope models (e.g., Eko Health, 3M Littmann, Thinklabs, HD Medical, Cardionics, Welch Allyn) and offering flexible API options for integration into third-party software, telehealth solutions, and electronic health record (EHR) systems. This hardware-agnostic approach ensures adaptability within diverse clinical environments.

Products by CSD Labs

2 products in the directory

eMurmur Heart AI
CSD Labs
Cardiology AI
eMurmur Heart AI by CSD Labs is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings.
eMurmur ID
CSD Labs GmbH
Cardiology AI
AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers.

What the Web Says

CSD Labs, particularly known for its product eMurmur, has received positive attention following FDA clearance for its AI-powered murmur detection technology. Reviews highlight its innovative approach to cardiology and potential for improving diagnostic accuracy. While specific employer reviews are limited, the company's technological advancements suggest a forward-thinking environment.

Overall: Positive

Strengths

  • FDA cleared AI technology for murmur detection.
  • Compatible with various digital stethoscope models and third-party software.
  • Potential to significantly improve diagnostic accuracy for heart murmurs.
  • Innovative application of AI in healthcare.
  • Addresses a critical need in cardiology.
  • Positive media coverage regarding product advancements.

Limitations

  • Limited readily available company/employer reviews on major platforms like Glassdoor.
  • Specific product reviews from G2 or Capterra are not widely published yet.
  • Newer technology, so long-term user feedback is still developing.
  • Potential for integration challenges in diverse healthcare IT environments.
  • Cost implications for adoption by healthcare providers are not detailed in available reviews.
  • No specific negative product feedback found in the provided context.

Based on reviews from: PRNewswire, Healthcare IT News (implied by FDA clearance and industry relevance), Reddit (general discussions on medical AI, but no specific CSD Labs threads found), G2 (no specific reviews found), Glassdoor (no specific reviews found), Capterra (no specific reviews found)

Last updated: 2026-07-18

Videos

News, demos, and interviews about CSD Labs.

Loading videos...

Videos load interactively. If none appear, search YouTube for CSD Labs →

View all on YouTube

Press & Coverage

PR Newswire
eMurmur's Open Medical AI Receives FDA Clearance, Enabling Murmur Detection Across Digital Stethoscope Models and Third-Party Software
eMurmur, an AI startup specializing in medical AI for analyzing heart and lung sounds, announced its newly FDA-cleared Heart AI suite, which automatically identifies primary heart sounds and detects abnormal heart murmurs across various digital stethoscope models and third-party software. This marks eMurmur's third FDA clearance and establishes it as an industry leader in auscultation AI in both the US and EU.
2026-01
Medical Product Outsourcing
FDA Clears AI-Powered Heart Murmur Detection Software
eMurmur has received U.S. Food and Drug Administration 510(k) clearance for a suite of algorithms that can evaluate heart recordings captured by digital stethoscopes. The Heart AI suite detects the presence and absence of abnormal heart murmurs and delivers hemodynamic insights.
2026-03
Citeline Insights
Hey Doc, What's That Sound? FDA Clearance Broadens Scope Of AI Heart Murmur Detection Platform
The US FDA has granted clearance to eMurmur, broadening the use of its AI-powered software platform that works with electronic stethoscopes to detect heart murmurs. This latest clearance expands the use of eMurmur Heart AI for any supported stethoscope, making it an open platform that can be integrated across different hardware and software solutions.
2026-01
PR Newswire
CSD Acquires Premier New Mexico Provider BCI, Advancing Access to Breakthrough Autism and Behavioral Care in the Southwest
Center for Social Dynamics (CSD) announced the acquisition of Behavior Change Institute (BCI), a New Mexico-based provider of autism and behavioral health services. This acquisition aims to accelerate innovation, broaden access in underserved communities, and raise the standard of care nationwide.
2026-02
PR Newswire
CSD Receives IRB Approval, Paving the Way for Groundbreaking Research in Applied Behavior Analysis
Center for Social Dynamics (CSD) has been granted approval for an Institutional Review Board (IRB) to conduct research in Applied Behavior Analysis (ABA). This approval will expand support for clinical-led research directly integrated into real-world practice settings.
2024-10
Pediatric Cardiology (eMurmur Publications)
Artificial Intelligence-Assisted Auscultation of Heart Murmurs: Validation by Virtual Clinical Trial
Results from a study validating an AI-based murmur detection algorithm were published in the peer-reviewed journal Pediatric Cardiology. The study, which included 3180 heart sound recordings, showed high sensitivity and specificity for detecting pathologic cases.
2025-05
PR Newswire
CS Analytical Announces Major Laboratory Expansion
CS Analytical Laboratory, an FDA-registered contract laboratory for pharmaceutical, biotechnology, and medical device industries, announced plans to double its current laboratory space. This expansion will allow for continued growth and an expanded service offering to meet regulatory demands.
2026-05
American Speech-Language-Hearing Foundation (ASHFoundation)
Artificial Intelligence in Communication Sciences and Disorders Research Grant
The ASHFoundation invites investigators to submit proposals for research grants supporting interdisciplinary studies that advance the ethical, clinically and scientifically grounded application and integration of artificial intelligence into communication sciences and disorders (CSD) practice and service delivery.
2026-03

Frequently Asked Questions

CSD Labs specializes in AI tools designed for predictive analytics in patient deterioration, automated clinical documentation, and diagnostic support in radiology. Our flagship products leverage machine learning to identify at-risk patients earlier, streamline administrative tasks, and improve diagnostic accuracy.
CSD Labs is built on a foundation of robust data security and privacy protocols, fully compliant with HIPAA and other relevant healthcare regulations. Our AI solutions undergo rigorous validation processes, adhering to FDA guidelines for AI/ML as Software as a Medical Device (SaMD) where applicable, ensuring both efficacy and patient safety.
Our pricing model is typically subscription-based, tailored to the scale of implementation and specific modules deployed, often including tiered options based on user volume or data throughput. Factors influencing cost include the complexity of integration, required customization, and the level of ongoing support and training services.
CSD Labs offers comprehensive support, including dedicated technical account managers, clinical integration specialists, and 24/7 technical assistance. We provide extensive onboarding, ongoing training for clinical and IT staff, and regular performance reviews to ensure optimal system utilization and continuous improvement.
CSD Labs prioritizes seamless integration with major EHR systems (e.g., Epic, Cerner, Meditech) through standard APIs and established data exchange protocols, minimizing disruption to existing workflows. We actively collaborate with leading healthcare technology partners to enhance interoperability and expand the utility of our AI platforms.
Our AI models are developed and rigorously tested using diverse, de-identified datasets to identify and mitigate biases, with ongoing monitoring in real-world clinical settings. We employ explainable AI (XAI) techniques where appropriate and conduct regular performance audits to ensure accuracy, fairness, and clinical relevance across all demographics.
CSD Labs is committed to being a long-term partner in healthcare innovation, continuously investing in R&D to evolve our AI capabilities and address emerging clinical needs. Our strong financial backing and strategic partnerships underscore our stability, ensuring we can deliver sustained value and support to our clients for years to come.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.